CBLL vs OWLT
CBLL: Ceribell develops wearable EEG systems and AI-powered software for rapid, automated seizure detection and brain monitoring in acute care settings. OWLT: Owlet provides FDA-cleared, wearable pediatric health monitors that bring clinical-grade data into the home to support infant wellness and parental peace of mind.
Side-by-side fundamentals
| Metric | CBLL | OWLT | Edge |
|---|---|---|---|
| Price as of 2026-08-07 close | $18.81 | $5.50 | |
| Market cap as of 2026-08-09 | $714M | $160M | |
| PEG as of 2026-08-09 | n/a | -0.02 | |
| Net margin as of 2026-08-09 | -63.5% | -43.0% | OWLT higher |
| Gross margin as of 2026-08-09 | +87.7% | +50.9% | CBLL higher |
| Operating margin as of 2026-08-09 | -68.3% | -10.3% | OWLT higher |
| ROE as of 2026-08-09 | -38.2% | -35.1% | OWLT higher |
| ROA as of 2026-08-09 | -30.9% | -59.3% | CBLL higher |
| Debt / equity as of 2026-08-09 | 0.14 | 0.52 | CBLL lower |
| Revenue growth (YoY) as of 2026-08-09 | +29.3% | +26.8% | CBLL higher |
| Revenue CAGR (3y) SEC XBRL | +40.3% | +15.2% | CBLL higher |
| Beta as of 2026-08-09 | 0.81 | 1.92 | |
| 1-year return as of 2026-08-07 close | +49.5% | -29.6% | CBLL higher |
Fundamentals: market data, as of 2026-08-09. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.